Projects funded by the NCN
Precision double strike against non-small cell lung cancer. Insights into multidirectional therapies and the landscape of mutational variation and drug resistance.
2024/53/B/NZ5/04013
Keywords:
lung cancer cell signalling resistance multidirectional targeted therapies EGFR tubulin kinases
Descriptors:
- NZ5_7: Human disease treatment
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ3_7: Signal transduction
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Principal investigator (from the host institution):
Number of co-investigators in the project: 11
Call: OPUS 27 - announced on 2024-03-21
Amount awarded: 3 367 200 PLN
Project start date (Y-m-d): 2025-02-14
Project end date (Y-m-d): 2029-02-13
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.